...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith-Oncology Pipeline
6
Mar 16, 2021 08:18AM
9
Mar 18, 2021 03:12PM
6
Mar 18, 2021 04:01PM
3
Mar 18, 2021 05:10PM
6
Mar 18, 2021 06:27PM
2
Mar 19, 2021 06:49AM
4
Mar 19, 2021 11:19AM
5
Mar 19, 2021 11:23AM
6
Mar 19, 2021 11:57AM
2
Mar 22, 2021 04:08PM
3
Mar 22, 2021 05:34PM
2
Mar 23, 2021 05:33AM
5
Mar 23, 2021 07:54AM
4
Mar 23, 2021 09:16AM
8
Mar 23, 2021 01:45PM

KOO - I can't answer your query about why Agoracom doesn't post ZHCLF like they do RVXCF on the RVX board. I can only surmise it is because OTC isn't recognized as a real exchange and yet the do for RVX because it is also on the TSX so gets some cred there. Not sure!

Also, I queried IR about the Prommissory Note details like rate and maturity date but just got a reply refusing to give that info.

2
Mar 23, 2021 03:27PM
2
Mar 23, 2021 04:33PM
Share
New Message
Please login to post a reply